Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARITY trial of postoperative cefazolin duration after lower extremity tumor endoprosthetic reconstruction
NL-OMON47195Recruiting
- Sponsor
- McMaster University
- Start
- Apr 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cefazolin in bone neoplasm and Bone and soft tissue sarcoma, sponsored by McMaster University. Started Apr 2017; status: recruiting.
02
Drugs
cefazolin
03
Conditions
bone neoplasmBone and soft tissue sarcoma
Beyond the preview
Go deeper on NL-OMON47195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47195.